In previous studies, PMA rarely have epidermal growth factor receptor(EGFR) mutations but frequently KRAS mutations(≥50%)17, 18, 19 which are quite different from nonmucinous adenocarcinomas. The gene discussed is EGFR; the disease is adenocarcinoma.